Cytochrome P450 dependent metabolism of the new designer drug 1-(3-trifluoromethylphenyl)piperazine (TFMPP) - In vivo studies in Wistar and Dark Agouti rats as well as in vitro studies in human liver microsomes

Author: Staack R.F.   Paul L.D.   Springer D.   Kraemer T.   Maurer H.H.  

Publisher: Elsevier

ISSN: 0006-2952

Source: Biochemical Pharmacology, Vol.67, Iss.2, 2004-01, pp. : 235-244

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content